Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.94 USD | -0.51% | -4.37% | -51.60% |
May. 28 | RBC Halves Price Target on Verastem to $16 From $32, Maintains Outperform Rating, Speculative Risk Qualifier | MT |
May. 24 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.60% | 99.78M | |
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+1.05% | 22.48B | |
-9.61% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B |
- Stock Market
- Equities
- VSTM Stock
- News Verastem, Inc.
- Verastem Says Ovarian Cancer Drug Combination Shows Objective Response Rate of 28% in Phase 2 Study